Ekso Bionics Holdings (EKSO) Cash from Operations (2016 - 2026)
Ekso Bionics Holdings has reported Cash from Operations over the past 14 years, most recently at 4331000.0 for Q4 2025.
- On a quarterly basis, Cash from Operations fell 202.23% to 4331000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 11801000.0, a 19.86% decrease, with the full-year FY2025 number at 11801000.0, down 19.86% from a year prior.
- Cash from Operations reached 4331000.0 in Q4 2025 per EKSO's latest filing, down from 2061000.0 in the prior quarter.
- The five-year high for Cash from Operations was 1433000.0 in Q4 2024, with the low at 4331000.0 in Q4 2025.
- The 5-year median for Cash from Operations is 2989000.0 (2021), against an average of 2977250.0.
- Peak YoY movement for Cash from Operations: skyrocketed 56.53% in 2023, then crashed 202.23% in 2025.
- Tracing EKSO's Cash from Operations over 5 years: stood at 3075000.0 in 2021, then dropped by 18.5% to 3644000.0 in 2022, then soared by 56.53% to 1584000.0 in 2023, then increased by 9.53% to 1433000.0 in 2024, then crashed by 202.23% to 4331000.0 in 2025.
- According to Business Quant data, Cash from Operations over the past three periods came in at 4331000.0, 2061000.0, and 3444000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.